Market Cap 1.88B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 6,962,006
Avg Vol 6,689,520
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 76%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Ed_Ng
Ed_Ng Jun. 3 at 9:59 PM
$ABCL I never repost your post before. You started it. Just a pos
0 · Reply
oceanbleu
oceanbleu Jun. 3 at 9:05 PM
$ABCL I closed only 1/3 of my 3.05$ long position per my post on June 1. If it closes below 6.28$ on Friday, there is a decent probability it will retest 5.2$ (possibly lower) before the next leg up.
0 · Reply
ObsidianClaw
ObsidianClaw Jun. 3 at 8:44 PM
0 · Reply
hagarone
hagarone Jun. 3 at 8:34 PM
$ABCL your post really speaks to your character.
0 · Reply
Ed_Ng
Ed_Ng Jun. 3 at 8:28 PM
$ABCL someone just sold 1.5M shares. You know who they are.
1 · Reply
bonecrack_benny
bonecrack_benny Jun. 3 at 8:25 PM
$ABCL 1.5M shares traded 8 min after close.
0 · Reply
Ed_Ng
Ed_Ng Jun. 3 at 8:23 PM
$ABCL "rarely". lol. Just a pos holding a pos stock.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 3 at 8:07 PM
$ABCL Still ~45m shares short on $ABCL as of 15 May. Nearly 22% of float. That's a $245M bet that it ain't going to work out. I'm happy to be on the other side of that trade.
0 · Reply
hagarone
hagarone Jun. 3 at 8:04 PM
$ABCL get a grip dude! I rarely post green or red
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 3 at 7:57 PM
$ABCL $ABCL AbCellera will be live at Jefferies tomorrow. Scheduled for 10:40AM CST:
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 22 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 23 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 23 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 23 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 23 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 4 weeks ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 7 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 5 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 10 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Ed_Ng
Ed_Ng Jun. 3 at 9:59 PM
$ABCL I never repost your post before. You started it. Just a pos
0 · Reply
oceanbleu
oceanbleu Jun. 3 at 9:05 PM
$ABCL I closed only 1/3 of my 3.05$ long position per my post on June 1. If it closes below 6.28$ on Friday, there is a decent probability it will retest 5.2$ (possibly lower) before the next leg up.
0 · Reply
ObsidianClaw
ObsidianClaw Jun. 3 at 8:44 PM
0 · Reply
hagarone
hagarone Jun. 3 at 8:34 PM
$ABCL your post really speaks to your character.
0 · Reply
Ed_Ng
Ed_Ng Jun. 3 at 8:28 PM
$ABCL someone just sold 1.5M shares. You know who they are.
1 · Reply
bonecrack_benny
bonecrack_benny Jun. 3 at 8:25 PM
$ABCL 1.5M shares traded 8 min after close.
0 · Reply
Ed_Ng
Ed_Ng Jun. 3 at 8:23 PM
$ABCL "rarely". lol. Just a pos holding a pos stock.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 3 at 8:07 PM
$ABCL Still ~45m shares short on $ABCL as of 15 May. Nearly 22% of float. That's a $245M bet that it ain't going to work out. I'm happy to be on the other side of that trade.
0 · Reply
hagarone
hagarone Jun. 3 at 8:04 PM
$ABCL get a grip dude! I rarely post green or red
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 3 at 7:57 PM
$ABCL $ABCL AbCellera will be live at Jefferies tomorrow. Scheduled for 10:40AM CST:
0 · Reply
8008track
8008track Jun. 3 at 7:26 PM
$ABCL give me $1 so I can go all in - literally.
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 3 at 6:33 PM
$ABCL $ABCL The timing of exercising stock options is intriguing 👀 1. Reporting Person: Booth Andrew (Chief Financial Officer) 2. Transaction Type: Stock Option Exercise 3. Transaction Details: Purchase of 250,000 shares (exercise price per share $0.19) 4. Derivative: Stock Option (purchase right) 250,000 shares exercised completed 5. Remaining Holdings: 445,600 shares (directly held) 6. Nature of Transaction: Increase in held shares after stock option exercise 7. Trading Plan Status: Not disclosed 8. Transaction Code: M (exercise)
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 3 at 5:47 PM
$ABCL Look at this job posting from $ABCL ... do you think they are planning on doing Phase 3 trials anytime soon? Title: Medical Director - Clinical Development - Endocrinology and Autoimmune Diseases Role Description: "Designing and authoring clinical protocols (Phase 1-3), investigator brochures, clinical study reports (CSRs), and regulatory documents (IND, CTA)" This posting has been up for 28 days. They are actively looking to get geared up for possibility of Phase 3 trials. This tells me they are bullish on seeing equivalent efficacy in abcl635. Nothing is guaranteed but it's a great sign! Good luck longs!
0 · Reply
Ed_Ng
Ed_Ng Jun. 3 at 5:11 PM
$ABCL no worry. You guys still have time to sell now and get out.
0 · Reply
tradersunion353
tradersunion353 Jun. 3 at 4:55 PM
$ABCL SCAM will be a SCAM Clowns how is that adding and loading working.
1 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High Jun. 3 at 4:38 PM
$ABCL Most of my watchlist is red today but 7% drop is hard to justify. Great opportunity to initiate / add as Q3 is around the corner.
2 · Reply
tradersunion353
tradersunion353 Jun. 3 at 4:31 PM
$ABCL Overhyped SCAM back to 3 dollars. You guys who are married to ABCL.. I am sure you guys must be feeling high for this drop.. Sellingg house and car and everuything to buy ABCL???
0 · Reply
hichemben
hichemben Jun. 3 at 3:47 PM
$ABCL Healthy pullback and expected, ABCL is a longterm play for the people who are willing to wait💎 Summer will be quiet, but H2 will be great 🚀
1 · Reply
Quadruple_Double
Quadruple_Double Jun. 3 at 3:31 PM
$ABCL imagine caring about a small 3% in the grand scheme of things 😂😂
1 · Reply
Ed_Ng
Ed_Ng Jun. 3 at 3:01 PM
$ABCL same to you only bashing on green day
0 · Reply
tradersunion353
tradersunion353 Jun. 3 at 2:52 PM
$ABCL Overhyped underperforming junk cannot even hold $6 share price such a disaapoint to real investors - not to those who are married to ABCL
0 · Reply
DeMampCamp
DeMampCamp Jun. 3 at 2:23 PM
$ABCL Just another day of buying the fear, the same ones making up rumors are the same ones selling. Bought with both Robinhood and Etrade! Let's see if we can get back above $6 today, I'm not highly confident so if we do then that would be excellent!
2 · Reply